Dr. Abud Bakri
👤 SpeakerAppearances Over Time
Podcast Appearances
Now, that time there was a shortage of semaglutide and then eventually terzapatide.
So the compound pharmacy game shifted into making these drugs, compounded versions.
So they're not the FDA approved versions.
But when there's a shortage of a medication, the compounders are allowed to make these drugs to meet the shortage.
And in fact, the FDA was reaching out to these people, telling them to do it.
Like Brigham was talking to him last week at the Enhance Games.
He was like, yeah, the FDA told us to make this stuff, and then they're getting us in trouble.
This is Brigham Bueller, who runs Ways to Well, and he ran a pharmacy for a long time, right?
We've never actually met in person.
One of the best ones.
Yeah.
Yes.
And they did.
And they jumped in very hard.
On the GLPs.
Yes.
And they made a lot of money off the GLP ones.
This was, you know, billions of dollars being made.
Were they selling them for less than standard pharma was selling?
They were less than the Ozempic pens.